Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

Silicon’s complex effects on arsenic in rice shaped by terrain and soil

September 9, 2026
Continue Reading
silicon’s-complex-effects-on-arsenic-in-rice-shaped-by-terrain-and-soil
Posted inBiotechnology

Cobimetinib boosts calreticulin and reshapes immunity in triple-negative breast cancer

September 9, 2026
Continue Reading
cobimetinib-boosts-calreticulin-and-reshapes-immunity-in-triple-negative-breast-cancer
Posted inBiotechnology

Dual radioligand therapy targets neuroendocrine bone metastases in pilot study

September 9, 2026
Continue Reading
dual-radioligand-therapy-targets-neuroendocrine-bone-metastases-in-pilot-study
Posted inBiotechnology

VMA21 loss disrupts autophagy and vesicle trafficking in X-linked myopathy

September 9, 2026
Continue Reading
vma21-loss-disrupts-autophagy-and-vesicle-trafficking-in-x-linked-myopathy
Posted inBiotechnology

X-ray fluorescence mapping and quantification of metal(loid)s in animal samples

September 9, 2026
Continue Reading
x-ray-fluorescence-mapping-and-quantification-of-metal(loid)s-in-animal-samples
Posted inBiotechnology

Band gap, refractive index, and reflectivity of InSb and PdSe₂ nanostructures vary with dimensionality

September 9, 2026
Continue Reading
band-gap,-refractive-index,-and-reflectivity-of-insb-and-pdse₂-nanostructures-vary-with-dimensionality
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

editor’s-corner:-fierce-medtech’s-top-10-stories-of-2024-chart-the-industry’s-highs-and-lows
Posted inMedical Technology

Editor’s corner: Fierce Medtech’s top 10 stories of 2024 chart the industry’s highs and lows

December 23, 2024
A look back at our top stories of 2024 sees them fall into two major themes: promise, and a realignment…
Read More
fda-approves-humacyte’s-off-the-shelf-artery-implant-for-vascular-trauma-repair
Posted inMedical Technology

FDA approves Humacyte’s off-the-shelf artery implant for vascular trauma repair

December 23, 2024
The FDA has granted a groundbreaking approval to Humacyte for its off-the-shelf, bioengineered blood vessel implant, designed to replace a…
Read More
ikena,-after-tough-year-of-layoffs,-merges-with-inmagene-to-focus-on-phase-2-dermatitis-prospect
Posted inBiotechnology

Ikena, after tough year of layoffs, merges with Inmagene to focus on phase 2 dermatitis prospect

December 23, 2024
After a year that saw Ikena Oncology trim back its workforce and pipeline, the oncology biotech thinks it has found…
Read More
rapt-re-rolls-after-flameout,-paying-$35m-for-challenger-to-novartis,-roche-drug
Posted inBiotechnology

Rapt re-rolls after flameout, paying $35M for challenger to Novartis, Roche drug

December 23, 2024
Rapt Therapeutics has charted a new course following the implosion of its lead program, agreeing to pay $35 million for a…
Read More
sanofi-pays-sk-bioscience-e50m-as-children’s-pneumococcal-vaccine-enters-phase-3
Posted inBiotechnology

Sanofi pays SK bioscience €50M as children’s pneumococcal vaccine enters phase 3

December 23, 2024
Sanofi is handing SK bioscience 50 million euros ($52 million) as the longtime partners take their next-gen pneumococcal conjugate vaccine…
Read More
phase-2-data-will-drive-biopharma-vc-investments-next-year:-pitchbook
Posted inBiotechnology

Phase 2 data will drive biopharma VC investments next year: PitchBook

December 23, 2024
Phase 2 trial data will continue to be the name of the game when it comes to VC investments into…
Read More
stockwatch:-wall-street’s-leaders-and-laggards-of-2024
Posted inGenetics

StockWatch: Wall Street’s Leaders and Laggards of 2024

December 21, 2024
2024 had its dazzling moments, but, in the end, it was a year of treading water for biopharma stocks, judging…
Read More
Posted inBiotechnology

Discover Astellas’ differentiated approach to innovation partnerships

December 20, 2024
As a global life sciences company, Astellas is passionate about partnering to advance life-changing treatments for patients. If you are…
Read More
clinical-trials-industry-to-grapple-with-new-tech,-additional-uncertainty-in-2025:-velocity-clinical-research-ceo
Posted inResearch

Clinical trials industry to grapple with new tech, additional uncertainty in 2025: Velocity Clinical Research CEO

December 20, 2024
Clinical trials in 2025 will be beset by rising costs and uncertain regulations while also benefiting from new technologies and…
Read More
galectin’s-mash-treatment-reduces-varices-but-fails-to-hit-statistical-significance-in-phase-3-trial
Posted inBiotechnology

Galectin’s MASH treatment reduces varices but fails to hit statistical significance in phase 3 trial

December 20, 2024
Galectin Therapeutics’ stock has halved since the company revealed its investigational drug failed to significantly reduce enlarged veins for people…
Read More

Posts pagination

Previous page 1 … 2,289 2,290 2,291 2,292 2,293 … 2,305 Next page
You May Have Missed
Posted inMedical Technology

Boston Scientific recalls spinal cord implant in wake of more than 1k serious injuries

Posted inMedical Technology

Boston Scientific cyberattack likely to have ‘material impact’ on financial results

Posted inMedical Technology

Guardant wins FDA nod for diagnostic guiding use of AstraZeneca’s Etcamah

Posted inMedical Technology

Novocure hit by cyberattack exposing patient data

Privacy Policy    Terms

Scroll to Top